Additional information
| Therapeutic Segment | Anti-Obesity |
|---|---|
| Dosage Form | Tablets |
| Specialities | Orthopaedic, Physician |
As directed by physician
Orlistat acts by binding covalently to the serine residue of the active site of gastric and pancreatic lipases. When administered with fat-containing foods, orlistat partially inhibits hydrolysis of triglycerides, thus reducing the subsequent absorption of monoaclglycerides and free fatty acids.
